Sign up for a free trial and join thousands of other leading professionals. Click here to start!

Fifth Disease (Erythema Infectiosum, Parvovirus B19 Infection) News

Home | Index > Health > A-Z Index > Fifth Disease (Erythema Infectiosum, Parvovirus B19 Infection)

TAKE THIS POLL
According to the White House, 650,000 jobs were created or saved by $150 billion in stimulus funds. Was it money well spent? (Oct. 30, 2009) Yes. No. Don't know.

Sort by: relevance (24 hours) relevance date

What Is Erythema Infectiosum? What Is Slapped Cheek Syndrome? 4 Nov 2009 13:50 GMT
... A blotchy bright red rash may appear, generally on ... congregate, such as schools, kindergartens and nurseries infection can spread rapidly. In a small minority ... cat versions of the virus, called canine parvovirus and feline panleukopenia virus. Parvovirus B19 infects ...
Health Matters USA : What is Erythema Muliforme ? 4 Nov 2009 22:52 GMT
... An acute inflammatory disorder involving the skin and mucous membranes. ... can be potentially severe. Stevens-Johnson syndrome or erythema multiforme major are the severe form of ... of cases. Other known causes are: viral infections, particularly the herpes simplex virus, bacterial infections, ...
Health Nation : What is Erythema Nodosum ? 4 Nov 2009 22:52 GMT
... Erythema nodosum is an inflammatory disease of the ... high in estrogen), sulfonamides, iodides and bromides. Infections are frequently linked with the development of ...
FDA Approves Labeling Update For REYATAZ(R) Capsules To Include 96-Week Data For Previously Untreated HIV-1 Infected Adult Patients 6 Nov 2009 23:30 GMT
... Bristol-Myers Squibb Company (NYSE: BMY) announced that the ... (LPV/r)-based regimen in previously untreated adult patients infected with HIV-1. Data from the study demonstrate ... demonstrated clinically significant hypersensitivity (e.g., Stevens-Johnson syndrome, erythema multiforme, or toxic skin eruptions) to any ...
FDA Approves Labeling Update for REYATAZ(R) (atazanavir sulfate) Capsules to Include 96-Week Data for Previously Untreated HIV-1 Infected Adult Patients 5 Nov 2009 23:31 GMT
... ) today announced that the U.S. Food and Drug Administration ... (LPV/r)-based regimen in previously untreated adult patients infected with HIV-1. Data from the study demonstrate ... demonstrated clinically significant hypersensitivity (e.g., Stevens-Johnson syndrome, erythema multiforme, or toxic skin eruptions) to any ...

FDA Approves Labeling Update for REYATAZ(R) (atazanavir sulfate) Capsules to Include 96-Week Data for Previously Untreated HIV-1 Infected Adult Patients (BIZ) 5 Nov 2009 23:30 GMT
... According to the most recent report from the , more ... HIV and the annual incidence of new infections was 56,300 in the U.S. It is ... demonstrated clinically significant hypersensitivity (e.g., Stevens-Johnson syndrome, erythema multiforme, or toxic skin eruptions) to any ...
FDA Approves Labeling Update for REYATAZ® (atazanavir sulfate) Capsules to Include 96-Week Data for Previously Untreated HIV-1 Infected Adult Patients 5 Nov 2009 23:31 GMT
... (atazanavir sulfate) 200 mg and 300 mg Capsules REYATAZ ... other antiretroviral agents for treatment of HIV-1 infection. This is based on analyses of plasma ... demonstrated clinically significant hypersensitivity (e.g., Stevens-Johnson syndrome, erythema multiforme, or toxic skin eruptions) to any ...
Virus kills pups at county shelter 4 Nov 2009 09:27 GMT
... Veterinary assistant Dana Habeck examines a 3-month-old puppy ... examines a 3-month-old puppy being treated for parvovirus Tuesday at Pine Creek Veterinary Clinic in ... kill it is with bleach. We've been disinfecting for weeks,” Fevinger said. “The staff can't ...
Safety Concerns with Etravirine; FDA Approves New Drug to Treat Psoriasis 2 Nov 2009 12:51 GMT
... The U.S. Food and Drug Administration issued a healthcare provider ... including Stevens-Johnson syndrome, toxic epidermal necrolysis, and erythema multiforme. Hypersensitivity reactions also have been reported ... transcriptase inhibitor prescribed for treatment of HIV infection. Available as 100mg tablets, etravirine usually is ...
Schering-Plough Reports Potent Antiviral Activity With Narlaprevir (SCH 900518), an Investigational, Once-Daily Protease 2 Nov 2009 22:50 GMT
... BOSTON, Nov. 2 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today ... of treatment in genotype 1 hepatitis C infection compared to the control group. We look ... pyrexia, headache, neutropenia, fatigue, anorexia, injection site erythema, and vomiting. In a study with PEGINTRON/REBETOL ...

Not satisfied with this news section? Make your own with the Newsletter Manager or try our other media monitoring services.

Schering-Plough Reports Potent Antiviral Activity With Narlaprevir (SCH 900518), an Investigational, Once-Daily Protease Inhibitor for Hepatitis C 2 Nov 2009 22:50 GMT
... Schering-Plough Reports Potent Antiviral Activity With Narlaprevir (SCH ... of treatment in genotype 1 hepatitis C infection compared to the control group. We look ... pyrexia, headache, neutropenia, fatigue, anorexia, injection site erythema, and vomiting. In a study with PEGINTRON/REBETOL ...
Schering-Plough Reports Potent Antiviral Activity With Narlaprevir (SCH 900518), an Investigational, 2 Nov 2009 22:54 GMT
... Schering-Plough Reports Potent Antiviral Activity With Narlaprevir (SCH ... of treatment in genotype 1 hepatitis C infection compared to the control group. We look ... pyrexia, headache, neutropenia, fatigue, anorexia, injection site erythema, and vomiting. In a study with PEGINTRON/REBETOL ...
FDA Approves Labeling Update for REYATAZ (atazanavir sulfate) Capsules to Include 96-Week Data for Previously Untreated 5 Nov 2009 23:55 GMT
... (atazanavir sulfate) 200 mg and 300 mg Capsules REYATAZ ... other antiretroviral agents for treatment of HIV-1 infection. This is based on analyses of plasma ... demonstrated clinically significant hypersensitivity (e.g., Stevens-Johnson syndrome, erythema multiforme, or toxic skin eruptions) to any ...
Statement re Positive Data in Combination Therapy Trial 3 Nov 2009 12:35 GMT
... Biocompatibles International plc is a leading medical technology ... alopecia, hand-foot syndrome (palmar plantar erythrodysaesthesia syndrome), erythema, pruritus, fatigue, pain (mouth, abdominal, bone, tumour, ... decrease, transient increase in transaminases. Uncommon: folliculitis, infection, hypersensitivity reactions (including skin reactions and urticaria), ...
U.S. Food and Drug Administration Issues Complete Response Letter Regarding Pegintron for Malignant Melanoma 2 Nov 2009 18:33 GMT
... U.S. Food and Drug Administration Issues Complete Response Letter Regarding ... bridging fibrosis or cirrhosis, and genotype 1 infection. (3) No safety and efficacy data are ... pyrexia, headache, neutropenia, fatigue, anorexia, injection site erythema, and vomiting. In a study with PEGINTRON/REBETOL ...
Amgen Announces Overall Survival Results for Vectibix(R) in First-Line Metastatic Colorectal Cancer 5 Nov 2009 13:35 GMT
... Amgen Announces Overall Survival Results for Vectibix(R) in First-Line ... were not limited to, dermatitis acneiform, pruritus, erythema, rash, skin exfoliation, paronychia, dry skin, and ... to the development of severe dermatologic toxicities, infectious complications, including sepsis, septic death, and abscesses ...
Amgen Announces Overall Survival Results for Vectibix(R) in First-Line Metastatic Colorectal Cancer / Phase 3 Results Reinforce Importance of KRAS Status 5 Nov 2009 13:42 GMT
... THOUSAND OAKS, Calif., Nov. 5 /PRNewswire-FirstCall/ -- today announced ... were not limited to, dermatitis acneiform, pruritus, erythema, rash, skin exfoliation, paronychia, dry skin, and ... to the development of severe dermatologic toxicities, infectious complications, including sepsis, septic death, and abscesses ...
Amgen Announces Overall Survival Results for Vectibix in First-Line Metastatic Colorectal Cancer 5 Nov 2009 15:19 GMT
... Amgen Announces Overall Survival Results for Vectibix in First-Line ... were not limited to, dermatitis acneiform, pruritus, erythema, rash, skin exfoliation, paronychia, dry skin, and ... to the development of severe dermatologic toxicities, infectious complications, including sepsis, septic death, and abscesses ...
Amgen Announces Overall Survival Results for Vectibix(R) in... 5 Nov 2009 16:36 GMT
... Phase 3 Results Reinforce Importance of KRAS Status THOUSAND OAKS, ... were not limited to, dermatitis acneiform, pruritus, erythema, rash, skin exfoliation, paronychia, dry skin, and ... to the development of severe dermatologic toxicities, infectious complications, including sepsis, septic death, and abscesses ...
Health Matters : What is Hereditary Spherocytosis ? 6 Nov 2009 14:52 GMT
... There are three types of red cell membrane disorders ... not all, aplastic crises are caused by infection with type B19 human parvovirus (HPV). In some cases, an abrupt increase ...

THESE STORIES ARE NOT PUBLISHED BY IPD GROUP, INC. AND THESE LINKS WILL TAKE YOU TO OTHER WEBSITES. SOME OF THESE WEBSITES REQUIRE THEIR OWN REGISTRATION TO READ THEIR STORIES. PLEASE READ THE DISCLAIMER FOR MORE DETAILS. >>>

Dog from North Side shelter becomes surrogate for African painted pups 4 Nov 2009 05:31 GMT
... Dog from North Side shelter becomes surrogate for African ... they can to protect the pups from infectious diseases, including common viruses such as rabies, ... common viruses such as rabies, distemper and parvovirus, that domestic dogs are vaccinated against. African ...
Dog becomes surrogate to African painted pups 4 Nov 2009 06:51 GMT
... Dog from North Side shelter becomes surrogate for African ... they can to protect the pups from infectious diseases, including common viruses such as rabies, ... common viruses such as rabies, distemper and parvovirus, that domestic dogs are vaccinated against. African ...
U.S. Food and Drug Administration Issues Complete Response Letter Regarding PEGINTRON(R) for Malignant Melanoma 31 Oct 2009 00:40 GMT
... Schering-Plough Corp. (NYSE: SGP) announced today the U.S. ... bridging fibrosis or cirrhosis, and genotype 1 infection. (3) No safety and efficacy data are ... pyrexia, headache, neutropenia, fatigue, anorexia, injection site erythema, and vomiting. In a study with PEGINTRON/REBETOL ...
Data Supporting Boceprevir Response Guided Therapy Presented at American Association for the Study of Liver Diseases (AASLD) Annual Meeting (PRN) 1 Nov 2009 22:30 GMT
... Boceprevir response guided therapy utilizes a unique 4-week lead-in ... disease. It is the most common blood-borne infection in America and Europe, and the most ... pyrexia, headache, neutropenia, fatigue, anorexia, injection site erythema, and vomiting. In a study with PEGINTRON/REBETOL ...
Data Supporting Boceprevir Response Guided Therapy Presented at American Association for the Study of Liver Diseases (AASLD) Annual Meeting 1 Nov 2009 22:30 GMT
... BOSTON, Nov. 1 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: ) today ... disease. It is the most common blood-borne infection in America and Europe, and the most ... pyrexia, headache, neutropenia, fatigue, anorexia, injection site erythema, and vomiting. In a study with PEGINTRON/REBETOL ...